Filters

Bid Antibody

Bid Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameBid Primary Polyclonal Antibody
Also known asBid PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenBid
SpecificityThis is a highly specific antibody against Bid
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range142-192/195
Subcellular locationHelical
SourceKLH conjugated synthetic peptide derived from mouse Bid
Gene ID number12122
Swiss ProtP70444
Tested Applications IF(IHC-P), IHC-P
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Counters the protective effect of Bcl-2, The major proteolytic product p15 BID allows the release of cytochrome c, Induces caspases and apoptosis
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names 2700049M22Rik, AU022477, BH3-interacting domain death agonist, BID, p22 BID, AI875481
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetBid
Short nameBid Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameBH3 interacting domain death a this GO nist (Antibody to)
Alternative techniqueantibodies
Identity 1050
Gene BID
Long gene name BH3 interacting domain death agonist
Locus 22q11, 21
Discovery year 1998-04-20
GenBank acession AF042083
Entrez gene record 637
Pubmed identfication 8918887 9721221
RefSeq identity NM_197966
Classification Endogenous ligands BCL2 homology region 3 (BH3) only
Havana BLAST/BLAT OTTHUMG00000150087

Similar products

Subscribe to our Newsletter